We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Phase 1 Study of IMGN289 in Adult Patients With EGFR-positive Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01963715
Recruitment Status : Terminated
First Posted : October 16, 2013
Last Update Posted : October 2, 2015
Information provided by (Responsible Party):
ImmunoGen, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : April 2015
  Study Completion Date : April 2015